Literature DB >> 19198580

Concomitant chemo-radiotherapy as standard therapy in limited-stage small-cell oesophageal cancer: a summary of 3 clinical cases and review of the literature.

Bertrand Vos1, Julien Gallez, Sébastien Debroux, Sandrine Roland, Alain Verhest, Paul Van Houtte, Ahmad Awada, Alain Hendlisz.   

Abstract

Small-cell carcinoma of the oesophagus (SCCO) is a rare and aggressive malignant tumour associated with a poor prognosis. Between 1994 and 2002, three patients with SCCO were treated in our institution, representing 1.96% (3 out of 153) of all oesophageal malignancies seen during this period. All of these patients had limited-stage SCCO at initial diagnosis and were treated by chemotherapy (cisplatin and etoposide) with concomitant radiotherapy. An initial complete response of the primary lesion was observed in all cases and a persistent complete remission in two of the cases. Chemo-radiotherapy should be considered as a valuable treatment alternative to surgery for limited-stage small-cell carcinoma of the oesophagus.

Entities:  

Mesh:

Year:  2008        PMID: 19198580

Source DB:  PubMed          Journal:  Acta Gastroenterol Belg        ISSN: 1784-3227            Impact factor:   1.316


  1 in total

1.  Survival benefit of radiotherapy to patients with small cell esophagus carcinoma: an analysis of Surveillance Epidemiology and End Results (SEER) data.

Authors:  Yaqi Song; Wanwei Wang; Guangzhou Tao; Weiguo Zhu; Xilei Zhou; Peng Pan
Journal:  Oncotarget       Date:  2016-03-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.